http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100329835-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B60Y2304-07 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B60Q5-003 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B62D1-046 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-06 |
| filingDate | 2000-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2002-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2002-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100329835-B1 |
| titleOfInvention | Th2 adjuvant including Ovalbumin adsorbed in aluminium hydroxide for treating Behcet's disease |
| abstract | The present invention relates to Th2 adjuvant, which is used as a treatment for Behcet's disease. When Ovalbumin adsorbed on aluminum hydroxide adjuvant is administered to an animal with Behcet's disease, Behcet's disease improves in about 70% of animals. I could see it. |
| priorityDate | 2000-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 150.